Maciej Cabanski
Company: Monte Rosa Therapeutics
Job title: Senior Director Biomarkers & CDx
Seminars:
Track Chair 11:02 am
day: Conference Day Two - Track 1
Molecular Glue Degraders for Non-Oncology Indications 12:30 pm
Introducing molecular glue degraders (MGDs) as a targeted protein degradation (TPD) approach Leveraging the application of MGDs in non-oncology indications, such as diseases associated with autoimmunity and inflammation Illuminating the main utility of Biomarkers in Targeted ProteinDegradationRead more
day: Conference Day One - Track 1
Chair’s Closing Remarks & End of 14th Clinical Biomarkers & CDx Europe Summit 2024 5:30 pm
day: Conference Day Two - PM